Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

NCT03850587 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Celecoxib 200mg
DRUG: Tramadol 37.5Mg+ Celecoxib 200mg
DRUG: Tramadol 75mg+ Celecoxib 200mg
DRUG: Tramadol 150mg+ Celecoxib 200mg

Sponsor

Yooyoung Pharmaceutical Co., Ltd.

Collaborators

[object Object]